LOS ANGELES — The definition of seizure clusters varies significantly across epilepsy monitoring units (EMUs), according to a new survey of expert opinion. The findings should prompt the development ...

Patients treated with 5-mg midazolam nasal spray were more likely than those given placebo to remain seizure free for 6 hours after treatment or have their seizure terminated within 10 minutes, with ...

Treatment of Prolonged Seizure with Diazepam Nasal Spray: A Post Hoc Cohort Analysis Prolonged seizures within a seizure cluster, treated with diazepam nasal spray within 5-15 minutes of seizure onset ...

San Diego, California — It's still early days, but brand-new formulations of rescue benzodiazepine could be in store for patients who have acute repetitive seizures (ARS). Promising phase 3 trial ...

SAN DIEGO, Aug. 31, 2023 /PRNewswire/ -- Neurelis, Inc. will present additional clinical findings from the completed long-term, open-label, repeat-dose safety study of VALTOCO for the treatment of ...

(RTTNews) - Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on delivering innovative medicines, announced that the FDA has granted Orphan Drug Exclusivity to Libervant (diazepam) ...

The Phase 3 open-label extension (OLE) study evaluated the safety of repeated, intermittent use of NAYZILAM in individuals living with epilepsy experiencing acute repetitive seizures, also known as ...